XERISOL Trademark

Trademark Overview

On Friday, December 4, 2020, a trademark application was filed for XERISOL with the United States Patent and Trademark Office. The USPTO has given the XERISOL trademark a serial number of 90359499. The federal status of this trademark filing is REGISTERED as of Tuesday, November 5, 2024. This trademark is owned by Xeris Pharmaceuticals, Inc.. The XERISOL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; pharmaceutical drug formulation and development services; providing information on drug technology platforms for the formulation and development of drugs and biologics
xerisol

General Information

Serial Number90359499
Word MarkXERISOL
Filing DateFriday, December 4, 2020
Status700 - REGISTERED
Status DateTuesday, November 5, 2024
Registration Number7559452
Registration DateTuesday, November 5, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements

Goods and ServicesPharmaceutical research and development; pharmaceutical drug formulation and development services; providing information on drug technology platforms for the formulation and development of drugs and biologics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 10, 2021
Primary Code042
First Use Anywhere DateFriday, November 30, 2018
First Use In Commerce DateFriday, November 30, 2018

Trademark Owner History

Party NameXeris Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChicago, IL 60601
Party NameXeris Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60601
Party NameXeris Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60601

Trademark Events

Event DateEvent Description
Wednesday, May 12, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, May 24, 2021ASSIGNED TO EXAMINER
Tuesday, December 8, 2020NEW APPLICATION ENTERED
Wednesday, February 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 26, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, May 26, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 26, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 26, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 16, 2021SOU EXTENSION 1 GRANTED
Thursday, December 16, 2021SOU TEAS EXTENSION RECEIVED
Thursday, December 16, 2021SOU EXTENSION 1 FILED
Saturday, December 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 19, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, May 27, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 27, 2022SOU EXTENSION 2 FILED
Friday, May 27, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 31, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 31, 2023SOU EXTENSION 3 FILED
Tuesday, January 31, 2023SOU EXTENSION 3 GRANTED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU EXTENSION 5 GRANTED
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 4 FILED
Wednesday, August 23, 2023SOU EXTENSION 4 GRANTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 5 FILED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024USE AMENDMENT FILED
Thursday, August 1, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, October 2, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 2, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 3, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 5, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

xerisol development pharmaceutical formulation drug platforms drugs biologics technology services research